Topic: Herceptin
HERCEPTIN HELPS DELIVER A WARHEAD Roche and ImmunoGen reported on a "guided missile" combination drug called T-DM1 that shrank tumors by 30% or more in one-third of critically ill, advanced breast cancer patients in a trial. The therapy combines Roche's Herceptin with ...
Novel drug combo boosts survival of breast cancer patients with advanced disease, study findsSome women with very advanced breast cancer may have a new treatment option. A combination of two drugs that more precisely target tumors significantly extended the lives of women ...
ZURICH (Reuters) - Roche Holding AG said on Wednesday three studies on its drugs used to treat early and advanced breast cancer showed good results. The Swiss drugmaker, the world's largest maker of cancer drugs, was due to present the results in ...
Some women with small breast tumors may have a greater risk of the cancer recurring after treatment than has been believed, and might benefit from taking the drug Herceptin, a new study suggests. Treatments like chemotherapy or Herceptin aren't usually recommended for ...
Drug developers, genomic companies strive for more personalized medicineDrug developers in clinical trials increasingly are evaluating biomarkers, the human traits that differentiate one of us from all others. The development of these assays likely will lead to a wave of personally-tailored drugs ...
From Dr Andrew Lawson Sir: Paul Robinson ('Let's get a sense of proportion about disproportion', 12 August) states that a key principle of moral philosophy is that 'the end cannot justify the means'. To which branch of moral philosophy does he refer? ...
Over the next few weekends, the gardens of 23 stately homes will be opened up to several thousand sponsored fun-runners who, demonstrating the typically huge generosity shown towards cancer charities by the British public, will raise As a result of their generosity, ...